38
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Hydrophilic-Lipophilic Drug Carrier Systems of Bead Cellulose and Isopropyl Myristate

Pages 1007-1015 | Published online: 20 Oct 2008
 

Abstract

Solid carrier systems of bead cellulose (BC) and isopropyl myristate (IPM) as a lipophilic excipient showed high release rates for low prednisolone and high IPM content and decreasing rates for increasing drug and decreasing IPM content. The release of griseofulvin was decreased by increasing IPM content. The release was controlled by the solubility of the drugs in IPM and water, the crystalline state of the drugs, and the weight ratio of the components and was varied in a wide range by change of the prescriptions. The products were prepared according to a dispersion-coevaporation process and were received asflowable powders consisting of spherical porous particles. IPM with dispersed drug was incorporated into the pores of the beads and also precipitated on the bead surface. Depending on the ratio of IPM to drug, more or less crystalline drug particles were suspended in the liquid IPM film or the drug was amorphous dissolved. Investigations of wettability and water uptake gave hints to more lipophilic properties. The advantage of the coprecipitates was the combination of a hydrophilic carrier and a lipophilic excipient as aflowable system for controlled release.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.